chemotherapy combined with immunotherapy group:chemotherapy combined with immunotherapy

2 trials

Sponsors

Cancer Hospital Affiliated of Shandong First Medical University, Chinese Academy of Medical Sciences Tumor Hospital

Conditions

Immune-resistant advanced non-small cell lung cancergastric cancer

Phase 2

Phase II clinical study of S-1 and oxaliplatin adjuvant chemotherapy combined with immunotherapy (DC plus CIK) in Locally advanced unresectable or metastatic gastric cancer

RecruitingChiCTR-IPR-15005923

Chinese Academy of Medical Sciences Tumor Hospitalgastric cancer

Start: 2015-02-11Updated: 2017-04-18

Open-label, randomized, phase II clinical study of camrelizumab combined with platinum-based doublet chemotherapy with or without low-dose intestinal irradiation as first-line treatment for advanced non-small cell lung cancer

Active, not recruitingChiCTR2600119639

Cancer Hospital Affiliated of Shandong First Medical UniversityImmune-resistant advanced non-small cell lung cancer

Start: 2026-03-15Updated: 2026-03-09

Related Papers

Autologous CIK cells combined with chemotherapy as the first-line treatment for locally advanced or metastatic gastric cancer is safe and feasible

Frontiers in Immunology2023-11-018 citations